Mergers & Acquisition in a Nutshell
Details
Get practical insights from our guest speaker, Gordon Ryerson, COO and Co-Founder of Crosstree Capital—a global leader in Health Sciences M&A, specializing in middle-market companies within the pharmaceutical services, diagnostics, and healthcare technology sectors.
Don't miss this chance to explore the exciting opportunities that M&A can offer for your future career!
Dress code: business casual
Speakers
Gordon Ryerson
COO & Co-Founder
Crosstree Capital
Gordon Ryerson has over 20 years of investment banking and strategic consulting experience across the pharmaceutical, medical device and pharma services industries.
After co-founding Crosstree Capital Partners, Ryerson was Managing Director for Novumed Life Sciences (later acquired by E&Y Europe) leading the Global Strategic Advisory practice for pharmaceutical and medtech in- and out-licensing strategies.
Ryerson has worked in the Life Sciences industry for more than 25 years, previously at OccamMD, William R. Hough & Co., and the Eckerd Drug Corporation. Ryerson holds a BS in Economics from Auburn University and a MBA from the University of South Florida.